Top Markets
Coin of the day
Filament Health Corp. Filament Health Corp.

Filament Health Corp.

FH
Rank in Stocks #36244
Filament Health Corp. focuses on the discovery and advanced extraction of... Filament Health Corp. focuses on the discovery and advanced extraction of natural psychedelic compounds. The firm actively cultivates psychedelic flora, conducts genetic investigations, develops extraction methodologies, and performs internal clinical trials. It then supplies its intellectual property and potential pharmaceutical agents to drug developers, scientific researchers, and other authorized organizations. Its corporate headquarters are located in Vancouver, Canada.
Share Price
$0.00733937
Last synced: 2025-05-21
Market Cap
$2.88M
Change (1 day)
-31.94%
Change (1 year)
0.00%
Country
CA
Trade Filament Health Corp. (FH)

Category

P/E ratio for Filament Health Corp. (FH)
P/E ratio as of 2026 TTM: 0
According to Filament Health Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Filament Health Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.